Why did CDC pause tests for rabies and mpox?
CDC temporarily paused some infectious-disease testing
The CDC has temporarily halted testing for several infectious diseases, including rabies and mpox, citing staffing shortages. The change affects the agency’s normal role of supporting state and local public health laboratories.
What happened
The CDC removed these diseases from the list of tests it conducts for state and local labs. The coverage links the decision to drastic staff reductions and departures, leaving the agency without enough capacity to continue the same breadth of testing.
Why it matters
Pausing centralized testing can reduce speed and consistency of lab confirmation for suspected cases. For diseases that require prompt detection—particularly those where post-exposure decisions or outbreak response depend on laboratory results—delays can complicate local public-health actions.
While the reporting frames this primarily as a resource problem, the practical impact is that surveillance and confirmation workflows may shift to local capacity, alternative testing routes, or later turnaround times.
What’s still clear from the reports
- Known: The pause includes rabies and mpox.
- Known: The driver is staffing shortages.
- Unclear: The specific duration of the pause and the exact effect on turnaround times were not detailed in the provided coverage.
For patients and communities, the immediate relevance is surveillance continuity: health departments may have to rely more heavily on their own lab capabilities while the CDC’s testing function is reduced.